Related by context. All words. (Click for frequent words.) 71 Submits NDA 69 Zorbtive TM 69 Initiates Phase III 69 Completes Patient Enrollment 69 Initiates Enrollment 69 novel histone deacetylase 68 Initiates Clinical Trial 68 Initiates Phase II 68 arsenic trioxide injection 68 Initiates Clinical 67 COLAZAL R 67 Ozarelix 67 lexidronam injection 67 MOVIPREP R 67 methylnaltrexone bromide 67 FOLOTYN ® 67 Meets Primary Endpoint 67 balsalazide disodium Capsules 67 FOR FURTHER INFORMATION ABOUT 67 Initiates Clinical Trials 67 Receives Orphan Drug 67 Toremifene 67 Initiate Clinical Trial 66 Tezampanel 66 rasagiline tablets 66 R Saizen R 66 Receives Orphan Drug Designation 66 JAK2 Inhibitor 66 Presents Preclinical 66 dextromethorphan quinidine 66 NDA Submission 66 Personalized Immunotherapy 66 Soriatane 66 Receives Approvable Letter 66 Announces Tentative Approval 66 Zenvia ™ 66 vapreotide acetate 66 SYCREST 66 acetonide FA 66 5 HT3 antagonist 66 Cellegesic 66 Granted Orphan Drug 66 TLK# 66 Febuxostat 65 Sanvar R 65 intranasal formulation 65 mertansine 65 LEP ETU 65 Acapodene R 65 sapropterin dihydrochloride 65 AVAPRO 65 testosterone buccal system 65 Raptiva R 65 IV Busulfex 65 Pegloticase 65 Submits Response 65 IL# PE#QQR 65 Elagolix 65 markets HP Acthar 65 MAb therapy 65 oral prodrug 65 Silodosin 65 ZEVALIN ® 65 Saizen ® 65 adenosine injection 65 Therapeutic Competitors Companies 65 BUPHENYL 65 TRISENOX ® 65 developing Zerenex ferric 65 Licenses Novel 65 Reports Preclinical Data 65 Tarceva TM 65 Begins Dosing 65 developing ACAPODENE 65 VIVITROL ® 65 PRN FDA Approves 65 AAG geldanamycin analog 65 Fludara ® 65 generation purine nucleoside 65 Completes Enrollment 65 Inhalation Aerosol 64 TRISENOX R 64 MAGE A3 ASCI 64 interferon gamma 1b 64 docetaxel Taxotere ® 64 IMiDs R 64 NUEDEXTA ™ 64 Vidaza azacitidine 64 REBETOL combination therapy 64 R MSCRAMM 64 Receives Milestone Payment 64 ThermoDox R 64 Luteinizing Hormone Releasing Hormone 64 FDA APPROVES 64 cinacalcet HCl 64 Gel repository corticotropin injection 64 Vascular Disrupting Agent 64 VISICOL R 64 antibody MAb 64 R lenalidomide 64 Files Investigational 64 Serostim ® 64 Receives Fast Track 64 HuMax TAC 64 Preotact R 64 Announces Poster Presentations 64 Presents Positive 64 ALN PCS 64 phase III isavuconazole 64 PNP inhibitor 64 ARRY # 64 Archexin 64 SUPPRELIN R LA 64 PF # [002] 64 Squalamine 64 Submits Biologics License Application 64 E1 INT TM 64 Adenuric R 64 Immunotherapeutic 64 Drug Candidate 64 Orally administered 64 Saforis 64 investigational humanized monoclonal antibody 64 ® lenalidomide 64 LibiGel ® 64 dasatinib Sprycel ® 64 samarium Sm 64 Phase 2b Clinical Trial 64 Demonstrates Positive 64 Milestone Payment 64 ABILIFY ® 64 Bicifadine 64 PDE4 inhibitor 64 Nasdaq AVNR 64 Shows Statistically Significant 64 EVIZON TM 63 Trobalt 63 Kuvan R 63 Cetrorelix 63 Presents Preclinical Data 63 RELISTOR ® 63 CRMD# 63 Clolar ® 63 Files IND 63 refractory chronic lymphocytic 63 treat chronic sinusitis 63 YONDELIS 63 Investigational Treatment 63 Phase III Clinical Trial 63 trospium chloride 63 Receive Milestone Payment 63 Therapeutic Competitors companiesandmarkets.com adEgemonye 63 Intravenous Human 63 Panzem R 63 Aztreonam Lysine 63 Testosterone MDTS ® 63 Initiates Phase 2b 63 Cloretazine ® 63 candidate deforolimus 63 Gonal f R 63 Initiates Phase 63 Hsp# Inhibitor 63 Parathyroid Hormone 63 SILENOR 63 ADP receptor antagonist 63 Vidaza R 63 R bendamustine hydrochloride 63 FDA Approvable Letter 63 SinuNase ™ 63 Orally Disintegrating Tablets 63 Aloxi ® 63 Teva Provides Update 63 BRILINTA 63 CIP TRAMADOL ER 63 Cutaneous T 63 CONBRIZA 63 ATL# [001] 63 Pafuramidine 63 Launches Generic Version 63 ELADUR TM 63 R#/MEM 63 Egrifta 63 IV APAP 63 Commence Phase 63 Gets FDA Clearance 63 Demonstrates Significant 63 desvenlafaxine 63 Initiates Dosing 63 DELATESTRYL R 63 Fast Track Status 63 Kepivance 63 subsidiaries visit http:/www.apricusbio.com 63 Aviptadil 63 Tostrex 63 Achieves Primary Endpoint 63 PEGINTRON TM 63 POSIDUR TM 63 Pimavanserin 63 PEGylated anti 63 Cloretazine 63 Entereg R 63 Aurora Kinase 63 diarrhea predominant irritable 63 Renvela ® 63 RECOTHROM R 63 Friedreich Ataxia FRDA 63 DURIN TM 63 Awarded Qualifying Therapeutic 63 Peginterferon alfa 2b 63 highly selective inhibitor 63 GW# [003] 63 Mycophenolate Mofetil 63 TYZEKA 63 Xcytrin R 63 5 lipoxygenase inhibitor 63 Phase IIb Trial 63 Phase #b/#a clinical 63 NasdaqGM NTEC today 63 Wafer polifeprosan 62 beta 1a 62 Androxal TM 62 ACTIQ ® 62 evaluating tivozanib 62 Cetuximab Erbitux 62 SPRYCEL ® 62 induced macular edema 62 lucinactant 62 IgG1 monoclonal antibody 62 Initiate Phase 62 Aflibercept 62 tiapamil 62 ALN HPN 62 BioDelivery Sciences Announces 62 receiving INTRON 62 thetreatment 62 TELINTRA 62 Oracea ® 62 Present Preclinical Data 62 Phase 2b Trial 62 telomerase therapeutic 62 histone deacetylase HDAC inhibitor 62 novel emulsion formulation 62 Announce License Agreement 62 oral salmon calcitonin 62 non nucleoside inhibitor 62 Potelligent Technology 62 SABER ™ 62 targeted radiotherapeutic 62 SinuNase TM 62 CYT# potent vascular disrupting 62 histamine dihydrochloride 62 Vimpat R 62 oral methylnaltrexone 62 successfully commercialize Iluvien 62 InterfeRx 62 Argatroban 62 Anturol TM 62 prostone 62 PROVIGIL ® 62 Romiplostim 62 TOCOSOL 62 memantine HCl 62 forodesine 62 eniluracil 62 Phase 2a Trial 62 Investigational Compound 62 #/#mg 62 GTC recombinant human 62 Sensipar ® 62 Pivotal Phase III 62 humanized monoclonal 62 Completes Dosing 62 Kyowa Kirin 62 Milestone Payments 62 Somatuline R Autogel R 62 BXT # 62 Myocet 62 ® tiagabine hydrochloride 62 Bezielle 62 adalimumab Humira 62 Prolongs Survival 62 Ecallantide 62 Commences Phase 62 PROSTASCINT R 62 dasatinib Sprycel 62 Single Dose 62 candidates Azedra TM 62 XIAFLEX ® 62 receptor tyrosine kinase inhibitor 62 Pazopanib 62 VYVANSE TM lisdexamfetamine 62 trastuzumab DM1 62 PREOS R 62 octreotide acetate 62 Selective Electrochemical Tumor Ablation 62 tubulin inhibitor 62 Expanded Indication 62 FDA Approvals 62 oxaliplatin Eloxatin 62 Gliadel R 62 LymphoStat B TM 62 Serostim R 62 Lubiprostone 62 Orapred ODT 62 IV FENTORA R 62 HDAC Inhibitor 62 Successfully Completes Phase 62 OMNARIS HFA 62 Vantas 61 ZARS Pharma 61 apricitabine ATC 61 Raptiva ® 61 Transdermal Patch 61 Degarelix 61 selective androgen receptor modulator 61 Presents Positive Preclinical 61 POSIDUR TM ELADUR TM 61 oxymorphone ER 61 Exherin 61 Romidepsin 61 Lispro 61 JAK inhibitor 61 Actimmune ® 61 alefacept 61 InNexus Biotechnology 61 Decitabine 61 ARIXTRA R 61 Busulfex 61 Commercialization Agreement 61 Tasimelteon 61 LIALDA TM 61 5 HT6 receptor 61 Prism Pharmaceuticals 61 Genasense ® oblimersen 61 Regeneron Pharma 61 Bellicum Pharmaceuticals Inc. 61 Anti Tumor 61 Bazedoxifene 61 Piperacillin 61 HFA MDI 61 Inhalation Solution 61 REVLIMID R 61 severe gastroparesis 61 QUADRAMET R 61 SAR# [002] 61 Inc. Nasdaq IMGN 61 OvaRex ® MAb 61 herpetic keratitis 61 Benazepril 61 ospemifene 61 FULL PRESCRIBING INFORMATION 61 Spiegelmer ® 61 Gout Drug 61 BEMA Granisetron 61 velafermin belinostat 61 Vicriviroc 61 peripherally acting 61 BCG refractory carcinoma 61 Earns Milestone Payment 61 CINTREDEKIN BESUDOTOX 61 Demonstrates Potential 61 pregabalin Lyrica 61 inhalation powder 61 small molecule thrombopoietin 61 acyclovir Lauriad R 61 RANK Ligand inhibitor 61 Phase IIb Clinical Trial 61 bardoxolone 61 Testosterone Gel 61 oral RSD# 61 RAPTIVA 61 docetaxel Taxotere R 61 PDX pralatrexate 61 Zemplar Capsules 61 vinorelbine tartrate 61 Pathway Inhibitor 61 Thrombin topical Recombinant 61 IAP inhibitors 61 Paris IPN Euronext 61 baminercept 61 sitagliptin metformin 61 Diabetic Neuropathy 61 GATTEX TM 61 Mylan Receives Approval 61 oral beclomethasone dipropionate 61 Recombinant Human 61 Omigard TM 61 Rheumatoid Arthritis Drug 61 Novel Oral 61 BioSante Pharmaceuticals Announces 61 Adjuvant Treatment 61 Milestone Payment From 61 Annamycin 61 R sorafenib tablets 61 XL# anticancer compounds 61 AMEVIVE 61 duloxetine hydrochloride 61 dihydrochloride 61 BioGeneriX 61 PGL# 61 Nasdaq ABII 61 JAK Inhibitor 61 visit www.genenews.com 61 Somatuline R Depot 61 Captisol enabled 61 cetuximab Erbitux R 61 Receives Marketing Authorization 61 hypoxia activated prodrug 61 thalidomide Thalomid 61 Systemic Delivery 61 NASDAQ ENMD 61 Phase Ib Clinical Trial 61 Multaq dronedarone 60 Complicated Skin 60 Onalta ™ 60 #mg Tablets [002] 60 OMP #R# 60 AMITIZA ® 60 cromolyn sodium 60 ATL# [002] 60 MGd 60 Patient Enrollment 60 Tibotec BVBA 60 Azacitidine 60 Temsirolimus 60 Advanced Renal Cell 60 First Patient Dosed 60 rhMBL 60 denileukin diftitox 60 microtubule inhibitor 60 lintuzumab SGN 60 Civacir 60 novel therapeutic antibodies 60 Rhucin ® recombinant 60 secondary hyperparathyroidism 60 sublingual tablets 60 Veregen TM 60 Captisol ® 60 Alpha interferons including 60 RhuDex ® 60 Octreotide 60 Migranal 60 Phase IIa Clinical Trial 60 fosbretabulin 60 GTC recombinant form 60 Eligard R 60 Kinase Inhibitor 60 CIMZIA r 60 Eligard ® 60 Adjunctive Therapy 60 RenaZorb TM 60 XL# XL# 60 Protexia ® 60 therapeutically inactive prodrug 60 registrational studies 60 PSN# [002] 60 miconazole MBT 60 TAXOL 60 Maribavir 60 synthetic peptide containing 60 Abstral ® 60 Oracea TM 60 Nasdaq CYCC Nasdaq CYCCP 60 Aliskiren 60 Zenpep 60 Enrolls First 60 evaluating picoplatin 60 benign prostatic hypertrophy BPH 60 FDA Orphan Drug 60 Patients Treated With 60 Xyrem ® 60 initiated Phase Ib 60 BENLYSTA ® 60 selective modulator 60 Therapeutic Vaccine 60 Submits Application 60 Kristalose ® lactulose 60 STELARA TM 60 Panzem ® 60 Remicade infliximab 60 briakinumab 60 Aceon 60 Release Capsules 60 overactive bladder VANTAS R 60 NASDAQ OGXI 60 AMMONUL R sodium phenylacetate 60 proprietary Capillary Aerosolization Technology 60 FDA Accepts 60 Prodarsan R 60 VALSTAR 60 GABITRIL 60 modafinil Tablets C 60 Nanobody 60 zanolimumab 60 Ixempra 60 Xolegel 60 modulator SERM 60 Combination REOLYSIN R 60 NASDAQ CLSN 60 TLR9 agonist 60 etanercept Enbrel 60 Oral Calcitonin 60 REVLIMID lenalidomide 60 itraconazole Sporanox 60 2 methoxyestradiol 60 aripiprazole Abilify 60 panitumumab Vectibix 60 psoriasis rheumatoid arthritis 60 MKC# MT 60 Zegerid OTC 60 STRIANT R 60 Dantrium R 60 treat opioid induced 60 Opterone R 60 FACTIVE R gemifloxacin 60 Kuvan sapropterin dihydrochloride 60 Savella ® 60 Receives Positive Opinion 60 Aganocide ® 60 Metformin HCl 60 Lamictal ODT 60 Levoleucovorin 60 formerly LymphoStat B 60 Study Evaluating 60 Positive Opinion 60 Proquin XR 60 KRN# 60 fentanyl buccal tablet 60 topical non steroidal 60 IND Application 60 lymphoid malignancies 60 targeted antifolate 60 XL# XL# XL# XL# 60 sorafenib tablets 60 Preotact 60 gefitinib Iressa 60 Velcade bortezomib 60 INCB# [001] 60 BiovaxID TM 60 IMiD 60 romazarit 60 ruxolitinib 60 paclitaxel Taxol R 60 IPSEN 60 oral Janus kinase 60 acadesine 60 markets Testim ® 60 Entocort 60 DNA demethylating agent 60 Hedgehog antagonist 60 Familial Adenomatous Polyposis FAP 60 ACOMPLIA R 60 Patient Enrolment 60 Firazyr 60 Alternext ALEHT 60 Serdolect ® 60 oral deforolimus 60 Solasia 60 Glatiramer Acetate 60 Nasdaq CTIC 60 synthetic retinoid 60 virus HCV protease inhibitor 60 Liprotamase 60 OTCQB CTIX 60 Biomarker Study 60 alfa 2a 60 PDUFA Date 59 Submits Supplemental 59 Allovectin 7 R 59 LymphoStat B belimumab 59 PANVAC VF 59 Exherin TM 59 Dementia Related Psychosis 59 please visit http:/www.atherogenics.com 59 Diabetic Macular Edema 59 clotrimazole 59 Psoriasis Drug 59 Generic Version Of 59 PI3K/Akt pathway inhibitor 59 Zytiga 59 Nipent R 59 hyaluronidase enzyme 59 Tech DVAX 59 Dose Escalation 59 overactive bladder VANTAS 59 commercialized DURECT 59 Soliris eculizumab 59 anti inflammatory NSAID 59 Maxy G# 59 sorafenib Nexavar 59 Albugon 59 MEZAVANT 59 Aganocide 59 IV acetaminophen 59 Protease Inhibitor 59 OTCBB PYTO 59 dual endothelin receptor antagonist 59 Tanespimycin 59 Onalta TM 59 Factor VIIa 59 technology visit http:/www.genmab.com 59 Aloprim TM allopurinol sodium 59 Vitrasert R 59 Increlex R 59 anticancer compound 59 First Patient Enrolled 59 THALOMID 59 Frozen Shoulder syndrome 59 aurora kinase 59 HyACT 59 methylnaltrexone 59 docetaxel Injection Concentrate 59 UPLYSO 59 ciprofloxacin hydrochloride 59 Reveals Positive 59 Itraconazole 59 molecular chaperone regulation 59 GTC NASDAQ GTCB 59 Omacetaxine 59 valtorcitabine 59 Investigational Oral 59 Therapeutic Competitors Report 59 erlotinib Tarceva ® 59 VaxImmune 59 CCR5 mAb 59 selective kinase inhibitor 59 trastuzumab DM1 T DM1 59 HCl capsules 59 Nasdaq VRTX today 59 Epratuzumab 59 NanoEmulsion 59 Vernalis plc 59 huC# DM4 59 Modrenal R 59 ESTRASORB R 59 selective antagonist 59 Generic Versions 59 Cyclooxygenase Inhibiting Nitric Oxide 59 CEQ# 59 Receives Complete Response 59 Ranolazine 59 Fentanyl Patch 59 Onconase 59 small molecule Hedgehog 59 administered concomitantly 59 Safinamide 59 Pyridorin 59 Injectable Suspension 59 Urocidin TM 59 Inc. NASDAQ ORXE 59 VivaGel ™ 59 Dose Ranging Study 59 ISTODAX 59 SNT MC# 59 post herpetic neuralgia PHN 59 pan HDAC inhibitor 59 Initiate Phase III 59 prokinetic agent 59 Evoltra ® 59 Lumacan 59 Dynepo TM 59 PDE# inhibitors 59 Frozen Shoulder Syndrome 59 Insegia 59 REVLIMID ® 59 Initiate Phase II 59 anti CD3 monoclonal 59 Zenvia TM 59 CDP# 59 Varespladib 59 IND Filing 59 Calcitonin 59 lidocaine hydrochloride monohydrate powder 59 Campto 59 candesartan cilexetil 59 CORLUX CORT # 59 Alkeran 59 ADL# novel 59 fluvoxamine maleate 59 Efficacy Results 59 Taiho Pharmaceutical 59 Plicera 59 Tracleer r 59 sodium benzoate prescription 59 TLR9 agonists 59 Irinotecan 59 rhIGF-I/rhIGFBP-3 59 MethyPatch 59 Locteron exclusively 59 Nasdaq SCLN 59 rilonacept 59 Somatuline 59 please visit www.middlebrookpharma.com 59 INSPIRE Trial Phase III 59 REG1 Anticoagulation System 59 ONCONASE R 59 oropharyngeal candidiasis OPC 59 faropenem medoxomil 59 Cethrin R 59 OMAPRO ™ 59 Darinaparsin 59 Generic Version 59 refractory cutaneous T 59 miconazole Lauriad R 59 Alligator Bioscience AB 59 Drug Fails 59 ATG Fresenius S 59 glucokinase activator 59 lamotrigine Lamictal 59 Submits Investigational 59 Files Shelf Registration Statement 59 Afatinib 59 erlotinib Tarceva 59 ALN TTR 59 BioNumerik 59 GRALISE 59 Pliaglis 59 valopicitabine NM# 59 Zavesca ® 59 Oral Insulin 59 FDA Okays 59 Akela Pharma Inc. 59 Deforolimus 59 Antitumor Activity 59 terlipressin 59 Ostarine TM 59 BioGlue R 59 carbamazepine phenobarbital phenytoin rifampin 59 Valortim TM 59 CTAP# Capsules 59 Phase IIb clinical trials 59 YONDELIS R 59 Risperidone Oral Solution 59 Preotact ® 59 Prosaptide 59 5 Fluorouracil 59 EP #R 59 drug ISA# 59 Ad5FGF 4 59 Nasdaq ACHN 59 XIAPEX 59 Synerx Pharma 59 Cancidas 59 Somatuline Depot 58 Difimicin 58 ZADAXIN ® 58 targeting CD# 58 TRIOLEX HE# APOPTONE HE# 58 Zeneus 58 Drug Eluting Stent System 58 Pemetrexed 58 ergot derivatives 58 Marketing Authorisation Application 58 SCIB1 58 LSE SHP.L 58 diabetic neuropathic pain 58 Phase 2a Clinical Trial 58 Major Depressive Disorder MDD 58 Antiangiogenic 58 TRO# 58 kidney urologic 58 Nasdaq OMER 58 Fentanyl TAIFUN R 58 PrevOnco 58 Acute Attacks 58 ANDA Filing 58 Lenocta 58 DepoDur 58 Tß4 58 RTP #i 58 HSP# inhibitor 58 Talabostat 58 novel MetAP 2 58 containing granisetron 58 REBETOL combination 58 Metastatic Melanoma 58 Xyfid TM 58 Phase III Trial 58 Valdoxan 58 Tigecycline 58 Clinical Trial Results 58 Auxilium anticipates 58 CAELYX 58 Martin Nicklasson CEO 58 forodesine hydrochloride 58 Submits IND 58 Nasdaq NRGN 58 Collaborators Present 58 Vaccine Adjuvant 58 cell lymphoma CTCL 58 Interferon beta 1b 58 Nanobody R 58 KRYSTEXXA TM pegloticase 58 NASDAQ OMER 58 Neulasta R 58 reslizumab 58 Grants Orphan Drug 58 Amrubicin 58 isoform selective 58 maleate 58 Pyridorin TM 58 Keppra ® XR 58 Cellegesic TM nitroglycerin ointment 58 lixivaptan 58 Hycamtin ® 58 anti infective treatments 58 Asentar TM 58 Inc. OTCBB OXIS 58 eritoran 58 Methylnaltrexone 58 Kamada AAT 58 DPX Survivac 58 cMET 58 Demonstrates Potent 58 palifermin 58 Announce Licensing Agreement 58 Vion Pharmaceuticals 58 Announce Merger Agreement 58 Prostate Cancer Vaccine 58 commercialize AzaSite 58 HGS ETR2 58 metformin hydrochloride 58 Bafetinib 58 Flamel Technologies Announces 58 Sign Licensing Agreement 58 Progenics Pharmaceuticals 58 Prestara 58 Zavesca R 58 Announcement acc 58 evaluating mipomersen 58 castrate resistant prostate cancer 58 dimesylate Attention Deficit 58 Receives NASDAQ 58 Antiviral Activity 58 RhuDex 58 Ganciclovir 58 chronic idiopathic thrombocytopenic purpura 58 Marketing Authorisation 58 Anidulafungin 58 bleeding pallor 58 Allovectin 7 r 58 Gamunex C 58 lapatinib Tykerb 58 PEG INTRON 58 Nicotine Vaccine 58 Monoclonal Antibody 58 Significantly Improves 58 Azedra 58 alkylating agent 58 Clinical Trial Evaluating 58 Ranexa R 58 Intravenous CP 58 intravenous formulations 58 Sensipar R 58 Recombinant interferon alpha 58 Loxapine 58 nucleoside analog 58 Plaque Psoriasis 58 Auxilium Pharma 58 multi kinase inhibitor 58 EGRIFTA TM 58 bevacizumab Avastin ® 58 Apaziquone 58 Lupus Drug 58 GA GCB 58 liver resection surgeries 58 AKT inhibitor 58 R roscovitine 58 rhLF 58 Nasdaq CLDX 58 Retacrit 58 Mimpara 58 Æterna Zentaris 58 MEK inhibitor 58 Etubics 58 REGENERX BIOPHARMACEUTICALS INC. 58 commercialize elagolix 58 TYGACIL 58 candidate epratuzumab 58 MUSE ® 58 HDL Selective Delipidation 58 NASDAQ NRGN 58 Phase III Clinical Trials 58 Luveris 58 Voluntarily Withdraw 58 autologous cellular immunotherapy 58 Gentamicin Surgical Implant 58 cathepsin K inhibitor 58 CAMPATH 58 DosePro TM 58 POSIDUR ™ 58 Octreolin 58 ROTATEQ 58 Nexavar prescribing 58 Breast Cancer Assay 58 Well Tolerated 58 TOCOSOL Camptothecin 58 Clinical Study Shows 58 mu opioid receptor antagonist 58 GLP toxicology studies 58 Ascend Therapeutics 58 vernakalant oral 58 Metadate CD 58 Nycomed GmbH 58 PDE# 58 Reminyl galantamine 58 APNB 58 efalizumab 58 ZK EPO 58 Gastrotech 58 Loramyc ™ 58 DIFICID ™ 58 Pivotal Clinical Trial 58 Generx TM 58 AEG# 58 orphan medicinal product 58 IN PATIENTS WITH 58 HuMax HepC TM 58 visit www.sciclone.com 58 omega interferon 58 Gonal f 58 ORENCIA R 58 HIV integrase inhibitor 58 Zenapax 58 huN# DM1 58 nitric oxide donating prostaglandin 58 Clevudine 58 Troxatyl 58 NOX E# 58 non splenectomized 58 Phase 1b clinical trials 58 Orphan Status 58 mTOR mammalian target 58 Simulect 58 metastatic malignant 58 Biolipox 58 Zirgan 58 Patent Covering 58 Aryplase 58 Calixa 58 Deferiprone 58 Pivotal Trial 58 mitogen activated ERK kinase 58 sodium Injection 58 AGGRASTAT R Injection tirofiban 58 Receives Tentative Approval 58 ONCASPAR 58 Inc. NASDAQ CVTX 58 atacicept 58 Nasdaq HALO 58 cinacalcet 58 indinavir Crixivan 58 Prochieve R 58 PKC# 58 Mimpara R 58 primary dysmenorrhea 58 Pennsaid Plus 58 Taro Receives 58 Anika Therapeutics 58 Tykerb lapatinib 58 flutamide 58 BZL# 58 miconazole Lauriad ® 58 Corp EPCT 58 RNAi Therapeutics 58 MacroMed 58 Spectrum Pharmaceuticals Announces 58 anti amnesic 58 Temodar ® 57 TM Drug Eluting 57 Regains NASDAQ 57 PEG SN# 57 painful diabetic neuropathy 57 GRAS Status 57 Migraine Drug 57 Icatibant 57 AzaSite Plus 57 sumatriptan succinate 57 Elocalcitol 57 Injection Site 57 Long Term Efficacy 57 Cerimon 57 Syntonix 57 Idera Pharmaceuticals 57 agent bevasiranib 57 humanized interleukin 6 57 pradefovir 57 alpha#beta# 57 myelodysplastic myeloproliferative diseases 57 Abstract Accepted 57 Vectibix panitumumab 57 Evoltra TM 57 submitted supplemental Biologics 57 OMP designation 57 ELIQUIS 57 Exelon rivastigmine 57 N acetylgalactosamine 6 57 PRTX 57 IAP inhibitor